SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Traders are linking ARBs rally to Robinhoods tokenized-stock activity on Arbitrum and potential revenue from its chain, viewing the partnership as evidence of growing adoption. Others question whether that activity benefits ARB holders, citing weak token value capture and ongoing unlocks.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Kodiaks positive Phase 3 DAYBREAK results have intensified competition concerns in wet AMD and weighed on Ocular Therapeutix. Traders disagree on whether AXPAXLIs SOL-1 results and planned NDA filing can preserve its differentiation, particularly on durability, against Kodiak and other retinal treatments.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

FDA approval of WELTRUZA, Tevas once-monthly under-the-skin olanzapine injection for schizophrenia, is the main catalyst, with a U.S. launch expected in the coming weeks. Traders are highlighting its simpler administration versus the existing long-acting option and reacting positively to the growth potential and fresh 52-week highs, though some posts are simply bullish price speculation.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle rose sharply despite TD Cowen trimming its price target while maintaining a Buy rating; traders focused on the retained rating and saw the revised target as supportive. The move fueled hopes for a rebound and speculation about short covering, though recent volatility and the post-earnings selloff remain concerns.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is drawing attention after its and Modernas personalized cancer-vaccine combination with Keytruda met Phase 3 recurrence-free and distant-metastasis-free survival endpoints in resected melanoma. Traders see the result as validation of Mercks oncology pipeline and a potential boost to the Keytruda franchise, while some question the rallys valuation because full trial data, overall-survival results and regulatory prospects remain uncertain.

TRON is a decentralized blockchain-based operating system designed to accelerate the decentralization of the internet and its underlying infrastructure. It serves as a global settlement layer for stablecoins and everyday digital purchases, providing a high-throughput environment to support large-scale decentralized applications. The network is governed by a decentralized autonomous organization (DAO), which allows the community to manage the protocol without a central authority. Its primary value proposition includes a unique resource model that utilizes bandwidth and energy to allow for high transaction volumes without traditional fee spikes.  The platform functions as a smart contract platform that enables the creation of decentralized applications and is compatible with the Ethereum Virtual Machine, allowing developers to easily migrate applications. TRON operates using a Delegated Proof of Stake consensus mechanism where token holders vote for 27 Super Representatives to verify transactions and maintain the ledger. This structure is built for scalability and fast finality, aiming to handle more transactions per second than many established legacy blockchains. Users can interact with the ecosystem for various purposes, including decentralized finance (DeFi) through platforms like JustLend DAO and decentralized storage via the BitTorrent File System.  Value moves through the system via its native utility token, TRX, which facilitates transactions and grants users access to network resources. Holders can lock their TRX in a staking mechanism to gain TRON Power, which is used to vote on network rules and elect Super Representatives, earning rewards for securing the network. Established by the TRON Foundation and led by founder Justin Sun, the project has transitioned into a community-led DAO. The ecosystem is supported by strategic partnerships with major global entities, including Samsung, which integrated TRON into its blockchain keystore, as well as BitTorrent, Opera, and Swisscom Blockchain.

Tron

TRX is drawing attention for range-bound price action, with traders repeatedly describing consolidation and watching support, resistance, and possible breakout levels. Sentiment is mixed: some see the coins resilience and stablecoin-transfer use as bullish, while others are frustrated by its slow movement or expect further downside.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys steep selloff and fresh lows are driving discussion, with traders citing weak sales and profitability, a dividend reduction, and franchisee financial distress as reasons for concern. Bulls point to high short interest and speculate about a turnaround or Peltz/Trian buyout, while bears argue that a squeeze is unlikely without improved fundamentals.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

AEROs sharp rally is being tied by traders to the anticipated AerodromeVelodrome merger and broader multichain expansion, which they see as a potential boost to liquidity and revenue beyond Base. The community is broadly bullish but debating whether momentum can clear psychological resistance or whether the move could fade into a pullback or sell-the-news reaction.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcytes VAX-31 met the primary endpoints in its pivotal Phase 3 OPUS-1 trial, with immune responses comparable to established pneumococcal vaccines and stronger responses on some additional serotypes. Traders are weighing that clinical win and future trial milestones against the companys large stock-and-convertible offering, dilution concerns, profit-taking, and sharp post-announcement volatility.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Traders point to CME futures access and a Grayscale filing as catalysts behind Bitcoin Cashs earlier rally, while continued price swings have fueled debate over whether it can recover or resume its decline. Some also cite the planned CashVM/Layla upgrade as a bullish catalyst, but skepticism about BCHs utility and momentum remains prominent.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dutch Bros is drawing attention after a steep selloff and repeated 52-week lows, with traders debating whether the decline reflects high valuation, consumer-spending pressures, rising growth costs, and competitionor is an overdone pullback despite continued expansion. Bulls are buying what they see as an oversold opportunity, while bears expect further weakness and question whether growth justifies the valuation.

Here's Why Dutch Bros (BROS) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Dutch Bros Stock Is in the Spotlight for All the Right Reasons. Here's Why It's a Buy Now.

Key PointsDutch Bros is on track to benefit from a rapid regional-to-national expansion...

20 Years of Buck for Kids: Dutch Bros and the Dutch Bros Foundation Rally with Customers to Raise More Than $1.3M for Local Youth

20 Years of Buck for Kids: Dutch Bros and the Dutch Bros Foundation Rally with Customers to Raise More Than $1.3M for Local Youth 20 Years of Buck for Kids: Dutch Bros and the Dutch Bros Foundation Rally with Customers to Raise More Than $1.3M for Local YouthPR NewswireTEMPE, Ariz., Oct. 7...

Can Cheesecake Factory's $13.5M AUVs Drive Its Next Growth Phase?

CAKE's $13.5M-plus AUVs and record weekly sales are supporting margin gains as unit growth and digital engagement drive its next phase.

Dutch Bros (BROS) Stock Declines While Market Improves: Some Information for Investors

Dutch Bros (BROS) concluded the recent trading session at $38.23, signifying a -1.14% move from its prior day's close.

Why Dutch Bros Stock Dropped 21% in September

Key PointsDutch Bros is reporting robust growth and growing profits...

Prediction: Here's What a $10,000 Investment in Dutch Bros Stock Could be Worth By 2029

Key PointsDutch Bros has 1,225 stores and plans to expand to 2,029 by 2029...

Prediction: Here's What a $10,000 Investment in Dutch Bros (BROS) Stock Could Be Worth by 2029

Key PointsDutch Bros' management team believes it can have 2,029 stores open by 2029, up from 1,225 today...

Dutch Bros (BROS) Stock Sinks As Market Gains: What You Should Know

Dutch Bros (BROS) closed the most recent trading day at $37.89, moving 1.61% from the previous trading session.

Starbucks to Close 250 Stores: Is This a Positive Reset for Now?

SBUX plans to close 250 North American stores as it resets the portfolio, while investing in locations with stronger performance potential.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

APP Vs CELH Vs BROS Vs AXON: Retail Traders Are Most Interested In Buying Post-Earnings Dips Of These 2 Stocks

Equity

Bearish Sentiment

$APP

$AXON

$BROS

$CELH

$APP, $AXON, $BROS, and $CELH all sold off sharply following Q2 earnings. Which of these earnings declines are you most interested in buying? Vote and explain your reasoning in the comments.

Which of these earnings declines are you most interested in buying - $APP, $AXON, $BROS, or $CELH?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.24	--	--	N/A
Q2 '26	$0.29	$0.33	13.94%	BEAT
Q1 '26	$0.15	$0.16	5.13%	BEAT
Q4 '25	$0.09	$0.17	79.74%	BEAT
Q3 '25	$0.17	$0.19	13.64%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

BROS Earnings

Upcoming Earnings: Q3 '26

Historical Earnings